N-Q 1 form.htm QUARTERLY REGISTRANT form

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

FORM N-Q

QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY

Investment Company Act file number 811-2192

THE DREYFUS PREMIER THIRD CENTURY FUND, INC. 
(Exact name of Registrant as specified in charter)

c/o The Dreyfus Corporation 
200 Park Avenue 
New York, New York 10166 
(Address of principal executive offices) (Zip code) 
 
Mark N. Jacobs, Esq. 
200 Park Avenue 
New York, New York 10166 
(Name and address of agent for service) 
 
Registrant's telephone number, including area code: (212) 922-6000 

Date of fiscal year end:    05/31 
Date of reporting period:    08/31/04 



FORM N-Q

Item 1. Schedule of Investments.
THE DREYFUS PREMIER THIRD CENTURY FUND, INC.     
Statement of Investments         
August 31, 2004 (Unaudited)         
 
Common Stocks-97.6%    Shares    Value($) 
 
Consumer Discretionary-14.7%         
Coach    175,000 a    7,376,250 
Dollar General    456,500    8,993,050 
Marriott International, Cl. A    243,500    11,554,075 
Staples    389,000    11,156,520 
Target    262,000    11,679,960 
Tiffany & Co.    173,500    5,369,825 
Viacom, Cl. B    195,000    6,495,450 
Walt Disney    382,500    8,587,125 
        71,212,255 
 
Consumer Staples-8.4%         
Estee Lauder Cos., Cl. A    225,500    9,910,725 
PepsiCo    245,500    12,275,000 
Procter & Gamble    130,500    7,304,085 
Walgreen    311,000    11,335,950 
        40,825,760 
 
Energy-1.8%         
Anadarko Petroleum    153,000    9,060,660 
 
Financial-9.6%         
American Express    195,000    9,753,900 
American International Group    159,700    11,377,028 
Citigroup    215,000    10,014,700 
Goldman Sachs Group    86,500    7,754,725 
Radian Group    172,500    7,641,750 
        46,542,103 
 
Health Care-25.5%         
Alcon    93,000    6,960,120 
Amgen    193,000 a    11,442,970 
Fisher Scientific International    143,500 a    8,175,195 
Forest Laboratories    195,000 a    8,940,750 
Genzyme    99,000 a    5,346,000 
Johnson & Johnson    302,000    17,546,200 
Medtronic    317,000    15,770,750 
Pfizer    700,000    22,869,000 
Stryker    129,500    5,866,350 
Waters    185,000 a    8,012,350 
WellPoint Health Networks    71,000 a    6,970,780 
Zimmer Holdings    82,500 a    5,882,250 
        123,782,715 
 
Industrial-9.6%         
Avery Dennison    119,000    7,395,850 


Danaher    279,500    14,371,890 
Dover    164,500    6,206,585 
Illinois Tool Works    57,500    5,249,175 
Tyco International    428,000    13,404,960 
        46,628,460 
 
Information Technology-28.0%         
Accenture    137,000 a    3,575,700 
Alliance Data Systems    169,500 a    6,474,900 
Analog Devices    211,500    7,343,280 
Cisco Systems    1,005,000 a    18,853,800 
Cognizant Technology Solutions    323,000 a    8,856,660 
Corning    649,000 a    6,567,880 
Dell    451,500 a    15,730,260 
Intel    588,000    12,518,520 
International Business Machines    100,500    8,511,345 
Microsoft    884,500    24,146,850 
Oracle    307,000 a    3,060,790 
QUALCOMM    244,000    9,284,200 
Symantec    225,500 a    10,814,980 
        135,739,165 
Total Common Stocks         
(cost $416,744,642)        473,791,118 
 
    Principal     
Short-Term Investments-2.2%    Amount($)    Value($) 
Certificates of Deposit-.0%         
Self Help Credit Union,         
1.50%, 9/14/2004    100,000    100,000 
U.S. Treasury Bills-2.2%         
1.29%, 9/2/2004    2,915,000    2,914,883 
1.29%, 9/16/2004    6,261,000    6,257,244 
1.37%, 9/23/2004    1,502,000    1,500,693 
        10,672,820 
 
Total Short-Term Investments         
(cost $10,773,273)        10,772,820 
 
Total Investments (cost $427,517,915)    99.8%    484,563,938 
 
Cash and Receivables (Net)    0.2%    969,311 
 
Net Assets    100.0%    485,533,249 
 
a Non-income producing.         
b Securities valuation policies and other investment related disclosures are hereby incorporated by 
reference to the annual and semi annual reports previously filed with the Securities and Exchange Commission 
on Form N-CSR.         
See notes to financial statements.         


Item 2. Controls and Procedures.

(a) The Registrant's principal executive and principal financial officers have concluded, based on their evaluation of the Registrant's disclosure controls and procedures as of a date within 90 days of the filing date of this report, that the Registrant's disclosure controls and procedures are reasonably designed to ensure that information required to be disclosed by the Registrant on Form N-Q is recorded, processed, summarized and reported within the required time periods and that information required to be disclosed by the Registrant in the reports that it files or submits on Form N-Q is accumulated and communicated to the Registrant's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

(b) There were no changes to the Registrant's internal control over financial reporting that occurred during the Registrant's most recently ended fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Registrant's internal control over financial reporting.

Item 3.    Exhibits. 
 
(a)    Certifications of principal executive and principal financial officers as required by Rule 30a-2(a) 
under the Investment Company Act of 1940. 

-2-


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

THE DREYFUS PREMIER THIRD CENTURY FUND, INC.

By:    /s/ Stephen E. Canter 
    Stephen E. Canter 
    President 
 
Date:    October 14, 2004 
 
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 
1940, this Report has been signed below by the following persons on behalf of the Registrant and in the 
capacities and on the dates indicated. 
 
By:    /s/ Stephen E. Canter 
    Stephen E. Canter 
    Chief Executive Officer 
 
Date:    October 14, 2004 
 
By:    /s/ James Windels 
    James Windels 
    Chief Financial Officer 
 
Date:    October 14, 2004 
 
EXHIBIT INDEX
 
    (a) Certifications of principal executive and principal financial officers as required by Rule 30a- 
    2(a) under the Investment Company Act of 1940. (EX-99.CERT) 

-3-